Pentixapharm Holding AG (XTER:PTP) Institutional Ownership: 1.63% (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:PTP Pentixapharm Holding AG XTER:PTP
22 GF Score
Price €1.98
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG Institutional Ownership?

Pentixapharm Holding AG XTER:PTP -9.17% 22 Institutional Ownership is 1.63% as of Jul. 14, 2026. GuruFocus rates XTER:PTP with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pentixapharm Holding AG's institutional ownership is 1.63%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pentixapharm Holding AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pentixapharm Holding AG's Float Percentage Of Total Shares Outstanding is 0.00%.

Pentixapharm Holding AG Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Pentixapharm Holding AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG Institutional Ownership Chart

Pentixapharm Holding AG Historical Data

The historical data trend for Pentixapharm Holding AG can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 1.24 1.24 1.36 1.38 1.71 1.71 1.71 1.71 1.63 1.63
XTER:PTP
22GF Score
Pentixapharm Holding AG XTER:PTP
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.63% mean?
Pentixapharm Holding AG (XTER:PTP) has a Institutional Ownership of 1.63% as of Jul. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Pentixapharm Holding AG and its competitors.
Is Pentixapharm Holding AG's Institutional Ownership too high?
Pentixapharm Holding AG's current Institutional Ownership is 1.63%. Overall, Pentixapharm Holding AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's Institutional Ownership compare to VRTX and REGN?
Pentixapharm Holding AG's Institutional Ownership of 1.63% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Pentixapharm Holding AG and its competitors. Pentixapharm Holding AG's current Institutional Ownership is 1.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (XTER:PTP) has a current Institutional Ownership of 1.63%. The current Institutional Ownership is 1.63%. Pentixapharm Holding AG's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Pentixapharm Holding AG (XTER:PTP), the current Institutional Ownership is 1.63% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pentixapharm Holding AG Business Description

Other Exchanges PTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
22GF Score

Get the complete analysis for XTER:PTP

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.98
Price